Cardinal Health Inc SEC Filings

Cardinal Health (CAH) Form 144 notice reports a proposed sale of 5,373 common shares through The Charles Schwab Corporation on the NYSE with an aggregate market value of $795,204.00. The filer acquired the shares as restricted stock units on 08/16/2024 (3,050 shares) and 02/15/2025 (2,323 shares). The filing states there were 238,793,647 shares outstanding and lists the approximate sale date as 08/19/2025. No securities were reported sold by the filer in the past three months, and no gifts or noncash payments are indicated.

Cardinal Health Form 144 notice: The filing reports a proposed sale of 13,500 shares of common stock through Merrill (Columbus, OH) with an aggregate market value of $2,009,030NYSE and total shares outstanding are reported as 238,793,647. The approximate sale date is 08/19/2025. The shares to be sold were acquired mostly on 08/15/2025 as restricted and performance stock vesting (3,863 restricted; 9,318 performance) and a smaller tranche on 02/15/2025 (319 restricted).

The filer certifies there are no undisclosed material adverse facts and notes no sales in the past three months. This is a routine insider sale notice required under Rule 144 describing the broker, quantity, acquisition dates and nature of acquisition.

Cardinal Health, Inc. announced the sale of $1.0 billion of senior notes: $600,000,000 of 4.500% Notes due 2030 and $400,000,000 of 5.150% Notes due 2035, under an effective Form S-3ASR registration statement. The offering was made through an underwriting agreement dated August 13, 2025, with Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC serving as representatives of the underwriters. The disclosure references the registration statement number and notes that the cover page interactive data file is embedded in the Inline XBRL document. The Form 8-K is signed by Aaron E. Alt, Chief Financial Officer, and dated August 14, 2025.

Michelle D. Greene, Chief Information Officer of Cardinal Health, Inc. (CAH), filed a Form 4 reporting a securities transaction dated 08/12/2025. The filing lists transactions in common shares tied to performance share units, shows a reported quantity of 16,362 (marked with an "A") and another listed amount of 34,968 (marked with a "D"); the row shows a price of $0. The explanatory note states these are performance share units that will settle on August 15, 2025.

The form was signed by James E. Barnett, Attorney-in-fact on 08/12/2025. The filing identifies Greene's title and gives a reporting address in Dublin, Ohio. The document does not provide total outstanding shares or percent ownership, so materiality relative to the company-wide share count cannot be determined from this filing alone.

Deborah Weitzman, an officer listed as "CEO, PSS Segment" at Cardinal Health (CAH), was recorded as acquiring 39,100 performance share units on 08/12/2025 that are scheduled to settle on August 15, 2025.

The award is reported at a $0 price and is described as performance share units that will settle to common shares on the stated settlement date. After the reported acquisition, Ms. Weitzman’s beneficial ownership is shown as 88,229 common shares held directly. The filing shows this transaction as an acquisition (code A) and Table II reports no derivative securities.

Form 4 disclosure from Cardinal Health, Inc. (CAH) reports that Snow Ola M, the companys Chief Human Resources Officer, filed a change in beneficial ownership on 08/12/2025. The filing documents transactions in common shares tied to performance-based awards and is marked as a filing by one reporting person.

The tabular section lists the numeric entries 31,813 and 55,351 and shows a price of $0. The filing explicitly states these figures reflect performance share units that will settle on August 15, 2025. The form is signed by /s/ James E. Barnett, Attorney-in-fact dated 08/12/2025.

Cardinal Health insider transaction summary: Mary C. Scherer, listed as Chief Accounting Officer and reporting person for Cardinal Health, reported an acquisition of 3,029 common shares recorded as performance share units tied to the issuer. The transaction date is listed as 08/12/2025 and the filing states these performance share units will settle on August 15, 2025. Following the reported transaction the filing shows 11,691 common shares beneficially owned by the reporting person. The entry lists a $0 price, consistent with compensation-settled awards. This filing records a routine equity award rather than an open-market purchase or sale.

Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health (CAH), reported an acquisition of equity tied to performance awards. The Form 4 shows a transaction dated 08/12/2025 in which 49,994 common-share equivalents were recorded as acquired; the filing explains these are performance share units that will settle on 08/15/2025. The reported price is $0, consistent with a compensatory grant rather than a market purchase. After the reported transaction, Ms. Mayer's beneficial ownership is listed as 105,104 common shares.

This disclosure documents an executive equity grant converting to common shares on settlement and updates insider holdings for regulatory transparency. Table II contains no derivative transactions; the entry is limited to the performance-share settlement described in the explanation.

Stephen M. Mason, an officer of Cardinal Health, Inc. (CAH), reported a non-cash acquisition on 08/12/2025. The filing shows 54,537 performance share units acquired that, per the explanatory note, will settle into common shares on August 15, 2025 at an effective price of $0. After this award, the report lists 89,514 shares beneficially owned following the transaction. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, James E. Barnett, on 08/12/2025. The filing identifies the reporting person as an officer with title shown as CEO, GMPD Segment.